A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia

Detalles Bibliográficos
Autores principales: Daver, Naval, Salhotra, Amandeep, Brandwein, Joseph M., Podoltsev, Nikolai A., Pollyea, Daniel A., Jurcic, Joseph G., Assouline, Sarit, Yee, Karen, Li, Mengsong, Pourmohamad, Tony, Samineni, Divya, Sumiyoshi, Teiko, Vaze, Anjali, Dere, Randall C., Ma, Connie, Cooper, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Correspondences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252033/
https://www.ncbi.nlm.nih.gov/pubmed/33617672
http://dx.doi.org/10.1002/ajh.26136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252033/
https://www.ncbi.nlm.nih.gov/pubmed/33617672
http://dx.doi.org/10.1002/ajh.26136

Ejemplares similares